Cyclosporine: A Review
The discovery and use of cyclosporine since its inception into clinical use in the late 1970s has played a major role in the advancement of transplant medicine. While it has improved rates of acute rejection and early graft survival, data on long-term survival of renal allografts is less convincing....
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2012-01-01
|
Series: | Journal of Transplantation |
Online Access: | http://dx.doi.org/10.1155/2012/230386 |
id |
doaj-c2ab94c217e343c6b5b3fcb58856033a |
---|---|
record_format |
Article |
spelling |
doaj-c2ab94c217e343c6b5b3fcb58856033a2020-11-24T22:58:03ZengHindawi LimitedJournal of Transplantation2090-00072090-00152012-01-01201210.1155/2012/230386230386Cyclosporine: A ReviewDustin Tedesco0Lukas Haragsim1Division of Nephrology and Hypertension, University of Oklahoma Health Sciences Center, 920 S. L. Young Blvd, WP 2250 Oklahoma City, OK 73104, USADivision of Nephrology and Hypertension, University of Oklahoma Health Sciences Center, 920 S. L. Young Blvd, WP 2250 Oklahoma City, OK 73104, USAThe discovery and use of cyclosporine since its inception into clinical use in the late 1970s has played a major role in the advancement of transplant medicine. While it has improved rates of acute rejection and early graft survival, data on long-term survival of renal allografts is less convincing. The finding of acute reversible nephrotoxicity and nephrotoxicity in nonrenal transplants has since led to the widely accepted view that there is a chronic more irreversible component to this agent as well. Since that time, there has been intense interest in finding protocols which seek to minimize and even avoid the use of calcineurin inhibitors altogether. We seek to review cyclosporine in terms of its mechanism of action, pathophysiologic, and histologic features associated with acute and chronic nephrotoxicity and recent studies looking to avoid its toxic side effects.http://dx.doi.org/10.1155/2012/230386 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Dustin Tedesco Lukas Haragsim |
spellingShingle |
Dustin Tedesco Lukas Haragsim Cyclosporine: A Review Journal of Transplantation |
author_facet |
Dustin Tedesco Lukas Haragsim |
author_sort |
Dustin Tedesco |
title |
Cyclosporine: A Review |
title_short |
Cyclosporine: A Review |
title_full |
Cyclosporine: A Review |
title_fullStr |
Cyclosporine: A Review |
title_full_unstemmed |
Cyclosporine: A Review |
title_sort |
cyclosporine: a review |
publisher |
Hindawi Limited |
series |
Journal of Transplantation |
issn |
2090-0007 2090-0015 |
publishDate |
2012-01-01 |
description |
The discovery and use of cyclosporine since its inception into clinical use in the late 1970s has played a major role in the advancement of transplant medicine. While it has improved rates of acute rejection and early graft survival, data on long-term survival of renal allografts is less convincing. The finding of acute reversible nephrotoxicity and nephrotoxicity in nonrenal transplants has since led to the widely accepted view that there is a chronic more irreversible component to this agent as well. Since that time, there has been intense interest in finding protocols which seek to minimize and even avoid the use of calcineurin inhibitors altogether. We seek to review cyclosporine in terms of its mechanism of action, pathophysiologic, and histologic features associated with acute and chronic nephrotoxicity and recent studies looking to avoid its toxic side effects. |
url |
http://dx.doi.org/10.1155/2012/230386 |
work_keys_str_mv |
AT dustintedesco cyclosporineareview AT lukasharagsim cyclosporineareview |
_version_ |
1725648575768035328 |